Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial
Crossref DOI link: https://doi.org/10.1208/s12248-014-9631-6
Published Online: 2014-06-19
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, Kelong
Jin, Jin
Maia, Mauricio
Lowe, John
Sersch, Martina A.
Allison, David E.
License valid from 2014-06-19